Quantitation of IgE Antibodies and Allergens by the Radioallergosorbent Test, RAST

1973 ◽  
Vol 45 (1-2) ◽  
pp. 55-56 ◽  
Author(s):  
S.G.O. Johansson ◽  
H. Bennich ◽  
T. Foucard
2003 ◽  
Vol 25 (11-12) ◽  
pp. 609-614 ◽  
Author(s):  
Sitti Wahyuni ◽  
Ronald Van Ree ◽  
Andarias Mangali ◽  
Taniawati Supali ◽  
Maria Yazdanbakhsh ◽  
...  

1991 ◽  
Vol 63 (5) ◽  
pp. 363-365 ◽  
Author(s):  
A. M. Blomqvist ◽  
I. G. K. Axelsson ◽  
D. Danielsson ◽  
J. Kiviloog ◽  
A. Ulander ◽  
...  

1980 ◽  
Vol 39 (4) ◽  
pp. 317-333 ◽  
Author(s):  
K.A. Kelly ◽  
G.M. Lang ◽  
P.G. Bundesen ◽  
V. Holford-Strevens ◽  
I. Böttcher ◽  
...  

1989 ◽  
Vol 121 (4) ◽  
pp. 501-504 ◽  
Author(s):  
Karl-Georg Petersen ◽  
Abdulnasser Khalaf ◽  
Hans-Joachim Zeisel ◽  
Danuta Stryjek-Kaminska ◽  
Lothar Kerp

Abstract. Clinical manifestations of allergy to biosynthetic hGH were not reported in 245 patients treated for one year. A sensitive radioallergosorbent test showed, however, the presence of anti-hGH IgE antibodies in the sera of 13%. All patients with anti-hGH IgE had also elevated concentrations of total serum IgE, similar to atopic persons (2459 ± 147 μg/l, normal 70 ± 8, 2p < 0.0001); 83% of all patients who had specific IgE antibodies to hGH had specific antibodies prior to treatment. Administration of hGH did not consistently change concentrations (up to 8 μg/l or affinities (< 107 to 1.3 × 109 l/mol) of the specific reagins. Anti-hGH IgE antibodies were related to atopy. Treatment with biosynthetic hGH did not significantly stimulate specific IgE.


Sign in / Sign up

Export Citation Format

Share Document